Crosspoint Capital Strategies’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Crosspoint Capital Strategies’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-223	Closed	-$8K	–	976
2015 Q2	$8K	Buy	+223	New	+$8K	﹤0.01%	561
2015 Q1	–	Sell	-92,484	Closed	-$3.18M	–	861
2014 Q4	$3.18M	Buy	+92,484	New	+$3.02M	1.11%	30

Crosspoint Capital Strategies's AUXL Position: Q3 2015 in Review

Crosspoint Capital Strategies sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2015, closing a stake of 223 shares — an estimated $8K sold.

Crosspoint Capital Strategies first reported a position in AUXL in Q4 2014 and held it in 2 quarters. The position peaked at $3.18M in Q4 2014. 0 funds tracked by Wall St. Rank hold AUXL as of Q3 2015.

Crosspoint Capital Strategies reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2015 after selling out during the quarter.
Crosspoint Capital Strategies sold 223 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2015, an estimated $8K.
Crosspoint Capital Strategies first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q4 2014 and held it in 2 quarters.
Crosspoint Capital Strategies's AUXILIUM PHARAMCEUTICALS INC position peaked at $3.18M in Q4 2014.
0 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2015, filed 25 Nov 2015.